Immune Checkpoint Inhibitors - Related Endocrinopathies
Jaydira del Rivero, MD
National Cancer Institute/NIH
Immune checkpoint inhibitors have broad oncologic indications. Immune checkpoint inhibitor therapy has been associated with a variety of side effects, including endocrinopathies. This session will discuss the endocrine pathology associated with the use of immune checkpoint inhibitors.
Jaydira del Rivero, MD
National Cancer Institute/NIH
Adina Turcu, MD, MS
University of Michigan